[go: up one dir, main page]

IT202000011056A1 - SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY - Google Patents

SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY Download PDF

Info

Publication number
IT202000011056A1
IT202000011056A1 IT102020000011056A IT202000011056A IT202000011056A1 IT 202000011056 A1 IT202000011056 A1 IT 202000011056A1 IT 102020000011056 A IT102020000011056 A IT 102020000011056A IT 202000011056 A IT202000011056 A IT 202000011056A IT 202000011056 A1 IT202000011056 A1 IT 202000011056A1
Authority
IT
Italy
Prior art keywords
gel
gel according
weight
alpha
hyaluronic acid
Prior art date
Application number
IT102020000011056A
Other languages
Italian (it)
Inventor
Giorgio Panin
Original Assignee
Hulka S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hulka S R L filed Critical Hulka S R L
Priority to IT102020000011056A priority Critical patent/IT202000011056A1/en
Publication of IT202000011056A1 publication Critical patent/IT202000011056A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)

Description

DESCRIZIONE DESCRIPTION

CAMPO DELL?INVENZIONE FIELD OF THE INVENTION

La presente invenzione attiene al campo dei prodotti igienizzanti per la pelle. Si descrive una nuova formulazione di gel igienizzante, particolarmente efficace nei confronti di batteri e virus, adatta ad applicazioni ripetute e prolungate nel tempo. The present invention pertains to the field of skin sanitizing products. A new formulation of sanitizing gel is described, particularly effective against bacteria and viruses, suitable for repeated and prolonged applications over time.

STATO DELLA TECNICA STATE OF THE ART

Prodotti igienizzanti sono ampiamente utilizzati per la pulizia e disinfezione di parti della pelle, in particolare mani, che sono particolarmente esposte al contatto con agenti infettanti presenti nell?ambiente. Questi prodotti possono essere formulati in vario modo, ad es. come gel acquosi comprendenti almeno un agente disinfettante in associazione con acqua e opportuni gelificanti. Il gel diluisce il disinfettante alla concentrazione target e costituisce una fase a viscosit? medio-bassa che, rispetto a formulazioni liquide, mantiene coesione dopo l?applicazione sulla pelle, non cola o gocciola via e d? tempo all?utilizzatore di spalmare la formulazione ricoprendo tutta l?area interessata; dopo l?applicazione, la matrice gelificata forma sulla pelle un sottile film che si oppone all?evaporazione e/o dispersione delle sostanze attive antibatteriche, prolungandone l?effetto; inoltre, rispetto a creme e unguenti, l?impiego del gel ? preferito in quanto dopo essicazione il prodotto non lascia traccia percettibile sulla pelle. Sanitizing products are widely used for cleaning and disinfecting parts of the skin, especially the hands, which are particularly exposed to contact with infectious agents present in the environment. These products can be formulated in various ways, e.g. as aqueous gels comprising at least one disinfectant agent in association with water and suitable gelling agents. The gel dilutes the disinfectant to the target concentration and forms a viscosity phase. medium-low which, compared to liquid formulations, maintains cohesion after application to the skin, does not drip or drip and d? time for the user to spread the formulation covering the entire affected area; after application, the gelled matrix forms a thin film on the skin which opposes the evaporation and/or dispersion of the antibacterial active substances, prolonging their effect; moreover, compared to creams and ointments, the use of the gel? preferred because after drying the product leaves no perceptible trace on the skin.

Questi prodotti agiscono sugli infettanti ambientali gi? presenti sulla superficie corporea da trattare, inibendone crescita e vitalit?; tuttavia l?effetto pu? anche essere preventivo, contrastando in questo caso l?adesione e crescita di nuovi agenti infettanti che vengono a contatto con la pelle successivamente all?applicazione del prodotto. Come tutti i trattamenti igienizzanti, l?effetto ? transitorio e necessita di essere rinnovato nel tempo con ulteriori applicazioni di prodotto se si desidera avere una protezione lunga e duratura; l?effetto disinfettante ? inoltre diretto aspecificamente contro il materiale organico in generale, dunque pu? coinvolgere la pelle stessa causando irritazione, secchezza, ecc. Tali limitazioni non sono state normalmente percepite come problema, in quanto il gel igienizzante era normalmente utilizzato per periodi brevi in alternativa all?acqua e sapone, proteggendo l?utilizzatore durante quei particolari periodi di attivit?, ad es. outdoor, durante i quali egli non ha la possibilit? di lavare le mani in modo convenzionale. Tuttavia, la costante crescita della popolazione, la sua concentrazione nelle aree urbane, l?aumentata mobilit? delle persone ha aumentato significativamente i contatti stretti tra le persone e la possibilit? di trasmissione di vecchie e nuove malattie infettive; di conseguenza l?impiego dei prodotti igienizzanti corporei e soprattutto la loro frequenza di uso da parte del singolo utilizzatore, sono andati via via aumentando. L?uso pi? frequente ha aggravato il problema dell?aggressivit? di questi prodotti verso la pelle; per ridurre questo impatto ? possibile ridurre la concentrazione di disinfettante, ma con un?indesiderabile perdita correlata di efficacia; d?altro canto ? stato anche proposto, con modesti risultati, di aggiungere al gel sostanze dermoprotettive: tuttavia questa non ? una via facile in quanto tali sostanze possono ridurre l?efficacia del disinfettante, modificare la reologia, stabilit? o caratteri organolettici del gel, ad es. lasciare tracce fastidiose dopo applicazione che stimolano l?utilizzatore a strofinare la mano, aumentando cos? i contatti con nuove ed ulteriori quantit? di agenti infettanti. La ricerca ? dunque fortemente impegnata nella ricerca di nuove ed efficaci combinazioni di disinfettanti, gelificanti e agenti dermoprotettivi che permettano di conciliare tra loro un significativo effetto disinfettante, una reologia di gel ottimale ed un forte effetto dermoprotettivo tale da permettere un uso prolungato e frequente del prodotto, senza causare danni alla superficie della pelle interessata. L?esigenza di prodotti con questi requisiti ? sempre pi? sentita, allo scopo di contrastare e proteggersi dalla crescente diffusione di nuove malattie, in particolare quelle ad alta pericolosit? e/o alto tasso di contagio. These products act on environmental infectants already? present on the body surface to be treated, inhibiting its growth and vitality; however, the effect can? also be preventive, in this case counteracting the adhesion and growth of new infectious agents that come into contact with the skin after applying the product. Like all sanitizing treatments, the effect is? transient and needs to be renewed over time with further product applications if long-lasting protection is desired; the disinfectant effect? moreover directed aspecifically against the organic material in general, therefore pu? involve the skin itself causing irritation, dryness, etc. These limitations were not normally perceived as a problem, as the sanitizing gel was normally used for short periods as an alternative to soap and water, protecting the user during those particular periods of activity, e.g. outdoor, during which he does not have the possibility? conventional hand washing. However, the constant growth of the population, its concentration in urban areas, the increased mobility? of people has significantly increased the close contacts between people and the possibility? transmission of old and new infectious diseases; consequently the use of body sanitizing products and above all their frequency of use by the single user, have gradually increased. The use more? frequent has aggravated the problem of? aggressiveness? of these products towards the skin; to reduce this impact ? possible to reduce the disinfectant concentration, but with an undesirable correlated loss of effectiveness; on the other hand ? It has also been proposed, with modest results, to add dermoprotective substances to the gel: however this is not? an easy way as these substances can reduce the effectiveness of the disinfectant, modify the rheology, stability? o organoleptic characteristics of the gel, e.g. leave annoying traces after application that stimulate the user to rub the hand, thus increasing? contacts with new and additional quantities? of infectious agents. Research ? therefore strongly engaged in the search for new and effective combinations of disinfectants, gelling agents and dermoprotective agents which allow to reconcile a significant disinfectant effect, an optimal gel rheology and a strong dermoprotective effect such as to allow prolonged and frequent use of the product, without cause damage to the affected skin surface. The need for products with these requirements? more and more heartfelt, in order to counteract and protect themselves from the growing spread of new diseases, especially those with high danger? and/or high rate of infection.

SOMMARIO SUMMARY

La Richiedente ha ora messo a punto una nuova formulazione igienizzante che supera in modo ottimale le suddette limitazioni, conciliando una forte attivit? anti-infettiva con il pieno rispetto della fisiologia della pelle, evitando cos? le conseguenze normalmente correlate all?uso continuativo dei comuni prodotti igienizzanti, quali irritazione, secchezza ecc. La formulazione ? in forma di gel acquoso ed ? principalmente caratterizzata dal fatto di contenere un agente disinfettante alcolico e una miscela dermoprotettiva comprendente: (a) vitamina E o un suo estere, (b) acido ialuronico o un suo sale fisiologicamente accettabile e (c) uno o pi? umettanti poliolici, preferibilmente scelti tra glicerina, glicole pentilenico e/o propilene glicol. I suddetti componenti hanno dimostrato di proteggere la pelle in modo intenso e anche sinergico, senza alcun pregiudizio all?attivit? disinfettante e alle propriet? del gel: ci? permette l?applicazione ripetuta nel tempo di quantit?/concentrazioni significative di agente/i disinfettante/i senza causare danno da contatto all?area di pelle trattata. The Applicant has now developed a new sanitizing formulation which optimally overcomes the aforementioned limitations, reconciling a strong activity? anti-infective with full respect for the physiology of the skin, thus avoiding? the consequences normally related to the continuous use of common sanitizing products, such as irritation, dryness, etc. The wording? in the form of aqueous gel and ? mainly characterized in that it contains an alcoholic disinfectant agent and a dermoprotective mixture comprising: (a) vitamin E or an ester thereof, (b) hyaluronic acid or a physiologically acceptable salt thereof and (c) one or more? polyol humectants, preferably selected from glycerin, pentylene glycol and/or propylene glycol. The aforementioned components have been shown to protect the skin in an intense and even synergistic way, without any prejudice to the activity? disinfectant and properties? of the gel: there? allows the repeated application of significant quantities/concentrations of disinfectant agent(s) over time without causing contact damage to the treated skin area.

DESCRIZIONE DETTAGLIATA DELL?INVENZIONE DETAILED DESCRIPTION OF THE INVENTION

Ai sensi della presente domanda, il termine ?gel? identifica un fluido omogeneamente gelificato, comprendente uno o pi? agenti gelificanti; tale gel presenta una viscosit? dinamica preferibilmente media o bassa, in particolare compresa tra 30.000 e 100.000 mPa. According to the present application, the term ?gel? identifies a homogeneously gelled fluid, comprising one or more? gelling agents; this gel has a viscosity? preferably medium or low dynamics, in particular between 30,000 and 100,000 mPa.

Il termine ?gel igienizzante? identifica un gel come sopra definito, che include uno o pi? agenti disinfettanti alcolici. Per ?agente disinfettante? si intende, come nell?accezione comune, una sostanza in grado di uccidere batteri e/o virus. The term ?sanitizing gel? identifies a gel as defined above, which includes one or more? alcoholic disinfectant agents. For ?disinfectant agent? it means, as in the common sense, a substance capable of killing bacteria and/or viruses.

Il termine ?gel acquoso? identifica un gel come sopra definito, comprendente acqua per almeno il 18% in peso sul peso della composizione totale. The term ?aqueous gel? identifies a gel as defined above, comprising water for at least 18% by weight of the total composition.

Tutte le percentuali qui indicate, salvo diverse indicazioni, sono da intendersi come percentuali in peso sul peso totale della composizione. All the percentages indicated herein, unless otherwise indicated, are to be understood as percentages by weight on the total weight of the composition.

Il termine ?miscela dermoprotettiva? identifica e definisce l?insieme dei componenti (a) ? (c), ovvero vitamina E o un suo estere, acido ialuronico o un suo sale e un umettante poliolico; il termine, ?miscela? indica la mera co-presenza di ciascuno dei suddetti componenti all?interno del gel, senza necessariamente richiedere che essi stessi siano separatamente miscelati / pre-miscelati tra loro. Pertanto, in fase di preparazione del gel, essi saranno aggiungibili indifferentemente in forma separata o pre-miscelata tra loro, ai rimanenti componenti del gel. Detti componenti (a) ? (c) possono essere indifferentemente presenti all?interno del gel in qualsiasi forma, ad es. disciolta, sospesa, emulsionata, ecc.. Ai sensi dell?invenzione, i componenti (a) ? (c) sono sempre co-presenti; tuttavia ci? non limita le miscele all?essere tri-componenti, in quanto ciascuno di essi pu? anche essere rappresentato da pi? composti appartenenti alla stessa classe. The term ?dermoprotective mixture? identifies and defines the set of components (a) ? (c), namely vitamin E or an ester thereof, hyaluronic acid or a salt thereof and a polyol humectant; the term, ?mixture? indicates the mere co-presence of each of the aforementioned components within the gel, without necessarily requiring that they themselves are separately mixed / pre-mixed with each other. Therefore, during the preparation of the gel, they can be added indifferently in separate form or pre-mixed with each other, to the remaining components of the gel. Said components (a) ? (c) they can be indifferently present within the gel in any form, e.g. dissolved, suspended, emulsified, etc. According to the invention, the components (a) ? (c) are always co-present; however there? does not limit the mixtures to? being tri-components, as each of them can? also be represented by pi? compounds belonging to the same class.

La vitamina E o un suo estere ? il primo componente della miscela dermoprotettiva. Il termine ?Vitamina E? include tutte le forme in cui detta vitamina ? presente in natura o come derivato di sintesi: esso include dunque indifferentemente i tocoferoli, tocotrienoli, le loro miscele, le loro isoforme ?, ?, ?, ? determinate in base al numero e posizione dei gruppi metile sull?anello del cromanolo. Particolarmente preferiti ai fini dell?invenzione sono l?alfa-tocoferolo e i suoi esteri, in particolare quelli scelti dal gruppo comprendente acetato, n-propionato e linoleato, con massima preferenza per ?-tocoferil acetato. All?interno della presente miscela dermoprotettiva, la vitamina E o il suo estere esercita un utile effetto antiossidante preventivo dell?infiammazione, vantaggiosamente associato alla sua liposolubilit?, che ne favorisce l?assorbimento da parte della pelle. Vitamin E or its ester? the first component of the dermoprotective mixture. The term ?Vitamin E? includes all forms in which said vitamin ? present in nature or as a synthetic derivative: it therefore indifferently includes tocopherols, tocotrienols, their mixtures, their isoforms ?, ?, ?, ? determined based on the number and position of the methyl groups on the chromanol ring. Particularly preferred for the purposes of the invention are alpha-tocopherol and its esters, in particular those selected from the group comprising acetate, n-propionate and linoleate, with maximum preference for ?-tocopheryl acetate. Within the present dermoprotective mixture, vitamin E or its ester exerts a useful antioxidant effect that prevents inflammation, advantageously associated with its liposolubility, which favors its absorption by the skin.

L?acido ialuronico, secondo componente della miscela, ? un ben noto glucosamminoglicano di origine naturale: pu? essere utilizzato in qualsiasi forma, salificata o no, e qualunque peso molecolare (qui intesi come peso molecolare pesato o weight average molecular weight). Tra i possibili sali, ? preferito il sale sodico. Tra i pesi molecolari, sono preferiti quelli compresi tra 20 e 1000 KDa. L?acido ialuronico esercita un?attivit? dermotrofica e dermoriparativa, favorendo tra l?altro la sintesi di collagene, una proteina essenziale alla funzionalit? della pelle. Hyaluronic acid, the second component of the mixture, is a well-known glucosaminoglycan of natural origin: pu? be used in any form, salified or not, and any molecular weight (herein understood as weighted molecular weight or weight average molecular weight). Among the possible salts, ? Sodium salt preferred. Among the molecular weights, those between 20 and 1000 KDa are preferred. Hyaluronic acid exerts an activity dermotrophic and dermoriparativa, promoting among other things the synthesis of collagen, a protein essential to the functionality? of the skin.

Il terzo componente della miscela dermoprotettiva ? un umettante poliolico: questa ? una classe ben nota di prodotti che include ad esempio glicerina, triacetato di glicerile, sorbitolo, xilitolo, maltitolo, glicoli quali ad es. glicol propilenico e glicole pentilenico, polioli polimerici quali ad es. il polidestrosio , ecc. e loro miscele. Quale componente della miscela dermoprotettiva, l?umettante assicura un?adeguata idratazione, stimolando tra l?altro l?elasticit? e la funzione traspirante della pelle. The third component of the dermoprotective mixture? a polyol humectant: this? a well known class of products including for example glycerin, glyceryl triacetate, sorbitol, xylitol, maltitol, glycols such as e.g. propylene glycol and pentylene glycol, polymeric polyols such as e.g. polydextrose, etc. and mixtures thereof. As a component of the dermoprotective blend, the humectant ensures adequate hydration, among other things by stimulating skin elasticity. and the breathable function of the skin.

La Richiedente ha specificamente valutato le quantit? dei componenti (a), (b) e (c), sia tra loro all?interno della miscela dermoprotettiva che in assoluto rispetto al gel, al fine di assicurare un adeguato effetto protettivo contro l?attivit? dermoaggressiva dei composti disinfettanti presenti nel gel. Pertanto, all?interno della miscela dermoprotettiva, i suddetti componenti variano preferibilmente entro le seguenti percentuali in peso, calcolate rispetto al peso totale di (a)+(b)+(c): (a) = 30?75%, (b) = 0,5?2,5 %, (c) = 24-70%. Has the Applicant specifically evaluated the quantities? of the components (a), (b) and (c), both between them within the dermoprotective mixture and in absolute respect to the gel, in order to ensure an adequate protective effect against the activity? dermoaggressive of the disinfectant compounds present in the gel. Therefore, within the dermoprotective mixture, the above components preferably vary within the following percentages by weight, calculated with respect to the total weight of (a)+(b)+(c): (a) = 30?75%, (b ) = 0.5?2.5%, (c) = 24-70%.

In alternativa o in aggiunta, quando valutati rispetto al gel disinfettante nel suo insieme, i suddetti componenti variano preferibilmente entro le seguenti percentuali in peso, calcolate rispetto al peso totale del gel: Alternatively or in addition, when evaluated with respect to the disinfectant gel as a whole, the aforementioned components preferably vary within the following percentages by weight, calculated with respect to the total weight of the gel:

(a) : 0,5-5%, pi? preferibilmente 1-4%, ancor pi? preferibilmente 3 ? 0,5%; (a) : 0.5-5%, plus? preferably 1-4%, even more? preferably 3 ? 0.5%;

(b) : 0,05?0,5 %, pi? preferibilmente 0,07-0,3%, ancor pi? preferibilmente circa 0.1 %; (b) : 0.05?0.5%, pi? preferably 0.07-0.3%, even more? preferably about 0.1%;

(c) : 0,5?5%, pi? preferibilmente 0,7-2,5%, ancor pi? preferibilmente 0,8-2,0% (c) : 0.5?5%, plus? preferably 0.7-2.5%, even more? preferably 0.8-2.0%

La composizione del gel igienizzante dell?invenzione comprende ulteriormente l?agente disinfettante, l?agente gelificante, possibili cogelificanti, eventuali regolatori di pH, e un adeguato quantitativo di acqua utile alla formazione del gel acquoso. The composition of the sanitizing gel of the invention further comprises the disinfectant agent, the gelling agent, possible co-gelling agents, possible pH regulators, and an adequate quantity of water useful for forming the aqueous gel.

L? ?agente disinfettante?, inteso ai sensi della presente invenzione, pu? essere un singolo agente disinfettante o una combinazione di pi? agenti disinfettanti. Tale agente ? un alcanolo scelto dal gruppo comprendente etanolo, isopropanolo e loro miscele L?agente disinfettante alcolico pu? essere presente preferibilmente in quantit? in peso compresa tra 50 e 80%, pi? preferibilmente tra 65 e 75% sul peso della composizione. Quando pi? agenti disinfettanti sono usati in combinazione, le suddette percentuali si intendono riferite al totale dei disinfettanti usati. L? "disinfecting agent", understood within the meaning of the present invention, can be a single disinfectant agent or a combination of more? disinfectant agents. This agent? an alkanol selected from the group comprising ethanol, isopropanol and mixtures thereof. The alcoholic disinfectant agent can? be present preferably in quantity? by weight between 50 and 80%, pi? preferably between 65 and 75% by weight of the composition. When more? disinfectant agents are used in combination, the above percentages refer to the total number of disinfectants used.

L? ?agente gelificante?, inteso ai sensi della presente invenzione, pu? essere un singolo agente gelificante o una combinazione di pi? agenti gelificanti. L?agente gelificante ? generalmente scelto tra le idrossialchilcellulose. Tra le idrossialchilcellulose sono particolarmente preferite l?idrossietilcellulosa, l?idrossipropilcellulosa e l?idrossipropilmetilcellulosa. Il gelificante ? preferibilmente presente in quantit? in peso compresa tra 0,2 e 2% sul peso della composizione, pi? preferibilmente tra 0,5 e 1,5%. Quando pi? agenti gelificanti sono usati in combinazione, le suddette percentuali si intendono riferite al totale dei gelificanti usati. L? "gelling agent", understood within the meaning of the present invention, can be a single gelling agent or a combination of more? gelling agents. The gelling agent? generally chosen among the hydroxyalkyl celluloses. Among the hydroxyalkylcelluloses, hydroxyethylcellulose, hydroxypropylcellulose and hydroxypropylmethylcellulose are particularly preferred. The gelling agent? preferably present in quantity? by weight between 0.2 and 2% on the weight of the composition, plus? preferably between 0.5 and 1.5%. When more? gelling agents are used in combination, the above percentages refer to the total number of gelling agents used.

Il ?regolatore di pH? inteso ai sensi della presente invenzione, pu? essere un singolo regolatore di pH o una combinazione di pi? regolatori di pH. Il regolatore di pH ? un composto di natura acida o basica in grado di riportare il pH della composizione entro un intervallo di standard di sicurezza per un?applicazione topica; ad es. quando ? richiesta una correzione basica, il regolatore o correttore preferito ? un?alcanolammina quale ad es. trietanolammina; quando invece ? richiesta una correzione acida, il regolatore preferito ? un acido organico quale ad es. acido citrico o acido lattico. Il regolatore di pH pu? essere utilizzato in quantit? adatte a raggiungere il pH target, ad esempio tra 0,01 e 0,3 %. Quando pi? regolatori di pH sono usati in combinazione, le suddette percentuali si intendono riferite al totale dei regolatori di pH usati. The ?pH regulator? intended within the meaning of the present invention, pu? be a single pH regulator or a combination of pi? pH regulators. The pH regulator ? a compound of acidic or basic nature capable of bringing the pH of the composition back within a range of safety standards for topical application; e.g. when ? Basic correction required, favorite adjuster or corrector? an alkanolamine such as e.g. triethanolamine; when instead ? request an acid correction, the preferred regulator ? an organic acid such as citric acid or lactic acid. The pH regulator can? be used in quantity? suitable for reaching the target pH, for example between 0.01 and 0.3%. When more? pH regulators are used in combination, the above percentages refer to the total number of pH regulators used.

Una composizione particolarmente preferita del gel secondo la presente invenzione ? la seguente: A particularly preferred composition of the gel according to the present invention ? the following:

Alfa-tocoferil acetato 2,5-3,5% Alpha-tocopheryl acetate 2.5-3.5%

Acido ialuronico 0,05-1,5% Hyaluronic acid 0.05-1.5%

Glicerolo 1,0-2,0% Glycerol 1.0-2.0%

Etanolo 68,0-75,0% Ethanol 68.0-75.0%

Idrossietilcellulosa 0,8-1,2% Hydroxyethylcellulose 0.8-1.2%

Acido lattico 0,02-0,04% Lactic acid 0.02-0.04%

Acqua: q.b. a 100,0% Water: to taste at 100.0%

L?invenzione include inoltre un procedimento per la preparazione del suddetto gel igienizzante. Nella sua accezione pi? generale, esso prevede il passaggio di formulare, insieme ad un agente disinfettante alcolico, un agente gelificante ed acqua, una miscela dermoprotettiva comprendente vitamina E o un suo estere, acido ialuronico o un suo sale farmaceuticamente accettabile e un umettante poliolico come sopra definiti. Come sopra indicato, il termine, ?miscela dermoprotettiva? indica la mera co-presenza di ciascuno dei componenti (a), (b), (c) all?interno del gel, senza necessariamente richiedere che essi stessi vengano separatamente miscelati/pre-miscelati tra loro. Pertanto, in fase di preparazione del gel, essi saranno indifferentemente aggiungibili in forma separata o pre-miscelata tra loro, ai rimanenti componenti del gel. Pi? in generale, tutti gli ingredienti del gel possono essere aggiunti contemporaneamente o separatamente e, nell?ultimo caso, in qualsiasi sequenza. The invention also includes a process for preparing the aforementioned sanitizing gel. In its most significant sense in general, it provides for the step of formulating, together with an alcoholic disinfectant agent, a gelling agent and water, a dermoprotective mixture comprising vitamin E or an ester thereof, hyaluronic acid or a pharmaceutically acceptable salt thereof and a polyol humectant as defined above. As indicated above, the term ?dermoprotective mixture? indicates the mere co-presence of each of the components (a), (b), (c) within the gel, without necessarily requiring that they themselves are separately mixed/pre-mixed with each other. Therefore, during the preparation of the gel, they can be added indifferently in separate form or pre-mixed with each other, to the remaining components of the gel. Pi? in general, all the ingredients of the gel can be added at the same time or separately and, in the latter case, in any sequence.

L?invenzione include inoltre il gel igienizzante come sopra descritto per uso in terapia e, pi? specificamente, per l?uso in un metodo di disinfezione della pelle, in particolare per eliminare e/o prevenire contaminazioni batteriche e/o virali della pelle, con riferimento preferito ma non esclusivo, alla pelle delle mani. L?invenzione include inoltre l?uso di un gel igienizzante come sopra descritto nella preparazione di un medicamento per uso nella disinfezione della pelle, in particolare per eliminare e/o prevenire contaminazioni batteriche e/o virali della pelle, con riferimento preferito ma non esclusivo, alla pelle delle mani. L?invenzione include inoltre un metodo per eliminare e/o prevenire contaminazioni batteriche e/o virali della pelle, con riferimento preferito ma non esclusivo, alla pelle delle mani, comprendente l?applicare il gel igienizzante come sopra descritto all?area di pelle interessata di un paziente che ne ha necessit?. The invention also includes the sanitizing gel as described above for use in therapy and, more specifically, for use in a skin disinfection method, in particular for eliminating and/or preventing bacterial and/or viral contamination of the skin, with reference preferably but not exclusively to the skin of the hands. The invention also includes the use of a sanitizing gel as described above in the preparation of a medicament for use in skin disinfection, in particular to eliminate and/or prevent bacterial and/or viral contamination of the skin, with preferred but not exclusive reference to the skin of the hands. The invention also includes a method for eliminating and/or preventing bacterial and/or viral contamination of the skin, with reference, preferably but not exclusively, to the skin of the hands, comprising applying the sanitizing gel as described above to the affected skin area of a patient who needs it.

L?invenzione viene ora descritta in dettaglio e a titolo non limitativo mediante i seguenti esempi sperimentali. The invention is now described in detail and without limitation by means of the following experimental examples.

PARTE SPERIMENTALE EXPERIMENTAL PART

Sono state realizzate le seguenti composizioni in accordo con la presente invenzione. Le percentuali degli ingredienti sono espresse in peso sul peso della formulazione finale. The following compositions have been made in accordance with the present invention. The percentages of the ingredients are expressed by weight on the weight of the final formulation.

Esempio 1 Example 1

Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%

Acido ialuronico: 0,1% Hyaluronic acid: 0.1%

Glicerolo: 1,0% Glycerol: 1.0%

Etanolo: 71,5% Ethanol: 71.5%

Idrossietilcellulosa 1,0% Hydroxyethylcellulose 1.0%

Aqua: 23,4% Aqua: 23.4%

Esempio 2 Example 2

Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%

Acido ialuronico: 0,1% Hyaluronic acid: 0.1%

Glicerolo: 2,0% Glycerol: 2.0%

Etanolo: 68,6% Ethanol: 68.6%

Isopropanolo 2,9% Isopropanol 2.9%

Idrossietilcellulosa 0,8% Hydroxyethylcellulose 0.8%

Aqua: 22,6% Aqua: 22.6%

Esempio 3 Example 3

Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%

Acido ialuronico: 0,1% Hyaluronic acid: 0.1%

Glicole pentilenico: 1,88% Pentylene glycol: 1.88%

Etanolo: 75,0% Ethanol: 75.0%

Idrossipropilcellulosa 0,8% Hydroxypropylcellulose 0.8%

Aqua: 19,2% Aqua: 19.2%

Acido Citrico: 0,02 % Citric acid: 0.02%

Esempio 4 Example 4

Alfa-tocoferil acetato: 3,0% Acido ialuronico: 0,1% Glicerolo: 2,0% Etanolo: 68,6% Isopropanolo 2,9% Idrossipropilmetilcellulosa 0,8% Aqua: 22,6% Esempio 5 Alpha-tocopheryl acetate: 3.0% Hyaluronic acid: 0.1% Glycerol: 2.0% Ethanol: 68.6% Isopropanol 2.9% Hydroxypropyl methylcellulose 0.8% Aqua: 22.6% Example 5

Alfa-tocoferil linoleato: 3,0% Alpha-tocopheryl linoleate: 3.0%

Acido ialuronico: 0,1% Hyaluronic acid: 0.1%

Glicerolo: 1,0% Glycerol: 1.0%

Etanolo: 71,5% Ethanol: 71.5%

Idrossietilcellulosa 1,0% Hydroxyethylcellulose 1.0%

Aqua: 23,4% Esempio 6 Aqua: 23.4% Example 6

Alfa-tocoferil n-propionato: 3,0% Acido ialuronico: 0,1% Glicole pentilenico: 2,0% Etanolo: 75,0% Idrossipropilcellulosa 0,8% Aqua: 19,07% Acido Lattico: 0, 03 % Esempio 7 Alpha-tocopheryl n-propionate: 3.0% Hyaluronic acid: 0.1% Pentylene glycol: 2.0% Ethanol: 75.0% Hydroxypropylcellulose 0.8% Aqua: 19.07% Lactic acid: 0.03% Example 7

Alfa-tocoferil acetato: 2,5% Alpha-tocopheryl acetate: 2.5%

Acido ialuronico: 0,2% Hyaluronic acid: 0.2%

Glicerolo: 1,5% Glycerol: 1.5%

Etanolo: 71,5% Ethanol: 71.5%

Idrossietilcellulosa 1,0% Hydroxyethylcellulose 1.0%

Aqua: 23,3% Aqua: 23.3%

Esempio 8 Example 8

Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%

Acido ialuronico: 0,1% Hyaluronic acid: 0.1%

Glicerolo: 2,0% Glycerol: 2.0%

Etanolo: 71,5% Ethanol: 71.5%

Idrossietilcellulosa 0,8 % Hydroxyethylcellulose 0.8%

Aqua: 22,57% Aqua: 22.57%

Acido Lattico: 0, 03 % In prove sperimentali su volontari, il gel igienizzante in accordo con i suddetti esempi ha mostrato un significativo effetto antibatterico e antivirale. La tollerabilit? del prodotto ? stata dimostrata mediante test su volontari senza che fossero rilevabili danni evidenti alla pelle, anche dopo uso frequente e continuativo. Lactic acid: 0.03% In experimental tests on volunteers, the sanitizing gel in accordance with the aforementioned examples showed a significant antibacterial and antiviral effect. The tolerability of the product ? been demonstrated through tests on volunteers without any obvious damage to the skin being detectable, even after frequent and continuous use.

Claims (16)

RIVENDICAZIONI 1. Gel igienizzante acquoso contenente una miscela dermoprotettiva a base di (a) vitamina E o un suo estere, (b) acido ialuronico o un suo sale fisiologicamente accettabile e (c) un umettante poliolico, in associazione con acqua, un agente disinfettante alcolico e un agente gelificante.1. Aqueous sanitizing gel containing a dermoprotective mixture based on (a) vitamin E or an ester thereof, (b) hyaluronic acid or a physiologically acceptable salt thereof and (c) a polyol humectant, in association with water, an alcoholic disinfectant agent and a gelling agent. 2. Gel in accordo con la rivendicazione 1, dove detta vitamina E ? presente in una o pi? forme scelte tra tocoferoli, tocotrienoli, le loro isoforme ?, ?, ?, ?, e loro esteri.2. Gel according to claim 1, wherein said vitamin E ? present in one or more forms selected from tocopherols, tocotrienols, their isoforms ?, ?, ?, ?, and their esters. 3. Gel in accordo con le rivendicazioni 1-2, dove detto acido ialuronico ha peso molecolare compreso tra 20 e 1000 KDa.3. Gel according to claims 1-2, wherein said hyaluronic acid has a molecular weight ranging from 20 to 1000 KDa. 4. Gel in accordo con le rivendicazioni 1-3, dove detto umettante poliolico ? scelto tra glicerina, triacetato di glicerile, sorbitolo, xilitolo, maltitolo, glicoli, polioli polimerici, o loro miscele.4. Gel according to claims 1-3, wherein said polyol humectant ? selected from glycerin, glyceryl triacetate, sorbitol, xylitol, maltitol, glycols, polymeric polyols, or mixtures thereof. 5. Gel in accordo con le rivendicazioni 1-4, dove detto componente (a) ? un estere di vitamina E scelto dal gruppo costituito da alfa-tocoferil acetato, alfa-tocoferil linoleato e alfa-tocoferil n-propionato, e/o l?acido ialuronico ? presente come suo sale sodico, e/o l?umettante poliolico ? scelto tra glicerina, glicole propilenico, glicole pentilenico o loro miscele.5. Gel according to claims 1-4, wherein said component (a) ? a vitamin E ester selected from the group consisting of alpha-tocopheryl acetate, alpha-tocopheryl linoleate and alpha-tocopheryl n-propionate, and/or hyaluronic acid ? present as its sodium salt, and/or the polyol humectant ? selected from glycerin, propylene glycol, pentylene glycol or mixtures thereof. 6. Gel in accordo con le rivendicazioni 1-5, comprendente le seguenti quantit? dei componenti (a), (b) e (c), in peso sul peso del gel: (a) 0,5-5,0%, (b) 0,05?0,5 %, (c) 0,5?5,0%.6. Gel according to claims 1-5, comprising the following quantities of components (a), (b) and (c), by weight on the weight of the gel: (a) 0.5-5.0%, (b) 0.05?0.5%, (c) 0, 5?5.0%. 7. Gel in accordo con la rivendicazione 6, in cui detto componente (a) ? alfa-tocoferil acetato ed ? contenuto in una quantit? di 2,5-3,5% in peso sul peso totale del gel.7. Gel according to claim 6, wherein said component (a) is alpha-tocopheryl acetate and ? contained in a quantity? of 2.5-3.5% by weight on the total weight of the gel. 8. Gel in accordo con le rivendicazioni 1-7, dove l?agente disinfettante alcolico ? scelto tra etanolo, isopropanolo e loro miscele.8. Gel according to claims 1-7, wherein the alcoholic disinfectant agent is selected from ethanol, isopropanol and mixtures thereof. 9. Gel in accordo con le rivendicazioni 1-8, dove l?agente disinfettante ? presente in quantit? in peso compresa tra 50% e 80%, pi? preferibilmente tra 65% e 75% in peso sul peso del gel.9. Gel according to claims 1-8, wherein the disinfectant agent is present in quantity? by weight between 50% and 80%, pi? preferably between 65% and 75% by weight on the weight of the gel. 10. Gel in accordo con le rivendicazioni 1-9, dove l?agente gelificante ? una idrossialchilcellulosa.10. Gel according to claims 1-9, wherein the gelling agent is a hydroxyalkyl cellulose. 11. Gel in accordo con le rivendicazioni 1-10, dove l?agente gelificante ? presente in quantit? in peso compresa tra 0,2 e 2,0%, preferibilmente tra 0,5 e 1,5%, sul peso della composizione.11. Gel according to claims 1-10, wherein the gelling agent is? present in quantity? by weight between 0.2 and 2.0%, preferably between 0.5 and 1.5%, based on the weight of the composition. 12. Gel in accordo con la rivendicazione 10 o 11, in cui detta idrossialchilcellulosa ? scelta dal gruppo costituito da idrossietilcellulosa, idrossipropilcellulosa e idrossipropilmetilcellulosa.12. Gel according to claim 10 or 11, wherein said hydroxyalkylcellulose ? selected from the group consisting of hydroxyethylcellulose, hydroxypropylcellulose and hydroxypropylmethylcellulose. 13. Gel in accordo con una qualunque delle rivendicazioni 1-12, comprendente ulteriormente un regolatore di pH, preferibilmente scelto tra acido citrico e acido lattico.13. Gel according to any one of claims 1-12, further comprising a pH regulator, preferably selected from citric acid and lactic acid. 14. Gel in accordo con una qualunque delle rivendicazioni 1-13, avente la seguente composizione:14. Gel according to any one of claims 1-13, having the following composition: Alfa-tocoferil acetato: 2,5-3,5%Alpha-tocopheryl acetate: 2.5-3.5% Acido ialuronico: 0,05-1,5%Hyaluronic acid: 0.05-1.5% Glicerolo: 1,0-2,0%Glycerol: 1.0-2.0% Etanolo: 68,0-75,0%Ethanol: 68.0-75.0% Idrossietilcellulosa 0,8-1,2%Hydroxyethylcellulose 0.8-1.2% Acido lattico 0,02-0,04% Lactic acid 0.02-0.04% Acqua: q.b. a 100,0%Water: to taste at 100.0% 15. Procedimento per la preparazione del gel igienizzante secondo le rivendicazioni 1-14, comprendente il formulare, insieme a detto agente disinfettante alcolico, detto agente gelificante ed acqua, una miscela dermoprotettiva comprendente vitamina E o un suo estere, acido ialuronico o un suo sale fisiologicamente accettabile, e un poliolo umettante.15. Process for the preparation of the sanitizing gel according to claims 1-14, comprising formulating, together with said alcoholic disinfectant agent, said gelling agent and water, a dermoprotective mixture comprising vitamin E or an ester thereof, hyaluronic acid or a salt thereof physiologically acceptable, and a humectant polyol. 16. Gel in accordo con le rivendicazioni 1-14, per l?uso in un metodo di disinfezione della pelle. 16. Gel according to claims 1-14, for use in a skin disinfection method.
IT102020000011056A 2020-05-14 2020-05-14 SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY IT202000011056A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102020000011056A IT202000011056A1 (en) 2020-05-14 2020-05-14 SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102020000011056A IT202000011056A1 (en) 2020-05-14 2020-05-14 SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY

Publications (1)

Publication Number Publication Date
IT202000011056A1 true IT202000011056A1 (en) 2021-11-14

Family

ID=71994804

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102020000011056A IT202000011056A1 (en) 2020-05-14 2020-05-14 SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY

Country Status (1)

Country Link
IT (1) IT202000011056A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003034994A2 (en) * 2001-10-23 2003-05-01 The Trustees Of Columbia University In The City Of New York Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
CN106074332A (en) * 2016-06-30 2016-11-09 赖保全 Whitening hand cream
CN108553387A (en) * 2018-06-21 2018-09-21 无锡市天爱装饰工程有限公司 A kind of three white bath foams
WO2018185508A1 (en) * 2017-04-04 2018-10-11 Gojo Industries Inc Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003034994A2 (en) * 2001-10-23 2003-05-01 The Trustees Of Columbia University In The City Of New York Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
CN106074332A (en) * 2016-06-30 2016-11-09 赖保全 Whitening hand cream
WO2018185508A1 (en) * 2017-04-04 2018-10-11 Gojo Industries Inc Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems
CN108553387A (en) * 2018-06-21 2018-09-21 无锡市天爱装饰工程有限公司 A kind of three white bath foams

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 27 August 2008 (2008-08-27), ANONYMOUS: "Mira-Cuticle Reducing Complex", XP055769039, Database accession no. 963064 *

Similar Documents

Publication Publication Date Title
JP7061802B2 (en) Anti-aging composition
EP2191828A1 (en) Antifungal pharmaceutical composition
WO2015002091A1 (en) Water-soluble hyaluronic acid gel and method for producing same
KR102101920B1 (en) Cosmetic composition for improving skin condition comprising human epidermal growth factor, peptides and functional materials
WO2008047680A1 (en) External preparation for skin
JP2010180213A (en) Antiseptic microbicide, and composition for applying to human body
CN112351777B (en) Composition for external use
CN106109259B (en) A kind of shampoo shower cream preventing stink with perspiration
SA112330609B1 (en) Oral care formula
KR20160044071A (en) Preservative composition containing methyl 3-acetyl-4-hydroxybenzoate as an active ingredient
KR20170122677A (en) Composition for photo-stabilizing polydatin or pharmaceutically acceptable salt thereof
KR102106212B1 (en) hypo-allergenic manicure composition by shellac for nail and toenail and its product method
JP5210527B2 (en) Antiseptic sterilizing moisturizer and composition for external application on skin and hair
IT202000011056A1 (en) SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY
PT1305057E (en) COMPOSITION OF MICROPARTICULAR BIOMATERIAL FOR MEDICINAL USE
KR101294092B1 (en) Wrinkle treatment cosmetic composition with fructose 1,6-diphosphate trisodium salt
ES2606233T3 (en) Compositions for the treatment of rosacea comprising chitosan and a dicarboxylic acid amide
JP6833307B2 (en) Colored bactericidal formulation based on bispiridinium alkanes
JP4734293B2 (en) Antiseptic disinfectant and human body composition
US20190343746A1 (en) Cosmetic composition including gamma-pga as active ingredient
EP3047841A1 (en) Stability improver of aromatic compound and method for improving stability of aromatic compound
US6949262B1 (en) Skin and mucosal treatment formulation
EP3226827B1 (en) Aluminium-free antiperspirant/deodorant compositions and method of preparing the same
KR20190042164A (en) Composition and method for non-atiseptic wet tissues containing the ingredient to inhibit microbial propagation
JP2001131025A (en) Cosmetic for scalp and hair